Sofia Wallström is Lif's new CEO

Sofia Wallström has been appointed as the new CEO of the industry organization Lif, the trade association for the research-based pharmaceutical industry in Sweden.

Today, Sofia Wallström is director general of Ivo, the Swedish Health and Social Care Inspectorate, and between 2013 and 2019 she was director general of TLV, the Swedish Agency for Dental and Pharmaceutical Benefits. She also has previous experience as, among other things, chancellor councilor at the Ministry of Finance.

In a report, criticism of Ivo's management and governance emerged recently, which Göteborgs-Posten has previously reported.

While the Government Office writes in a press release that Sofia Wallström is stepping down from her position at Ivo, at her own request as of September 30, Lif announces that she will become the new CEO of the industry organization.

– I am very much looking forward to being a part of this dynamic industry and contributing to even more co-creation and partnership for accessible and sustainable care for all patients, says Sofia Wallström, in a press release.

Lif has been looking for a new CEO since Johan Färnstrand left the job after a year on the post in mid-March. Karolina Antonov, former head of analysis, has since been acting CEO of Lif.

Sofia Wallström takes office on the first of October as the new CEO of Lif.

Artikeln är en del av vårt tema om News in English.

Kommentera en artikel
Utvalda artiklar


Sänd till en kollega